10% Owner Michael Skaff and V-Co Investors 3 LLC Acquire $7.17M in Vivos Therapeutics Stock and Warrants

summarizeSummary

10% owners Michael C. Skaff and V-Co Investors 3 LLC acquired $7.17 million in Vivos Therapeutics stock and warrants, including a debt conversion, representing over 50% of the company's market cap.

check_boxKey Events

• Significant Insider Acquisition

  10% owners Michael C. Skaff and V-Co Investors 3 LLC acquired $7,170,000 worth of Vivos Therapeutics securities, including common stock and various warrants, on March 31, 2026.

• Substantial Capital Infusion

  The acquisition includes the conversion of a $1.4 million bridge promissory note into common stock and the purchase of pre-funded warrants, Series A common stock warrants, and Series B common stock warrants, all priced at $1.34 per unit/share.

• Major Stake Relative to Market Cap

  The total transaction value of $7.17 million represents over 50% of the company's current market capitalization, indicating a very significant capital commitment.

• Expands on Prior Disclosure

  This Form 4 provides detailed transaction data, significantly expanding on the $2.39 million private placement previously disclosed in a Schedule 13D filed on the same day by V-Co Investors.

auto_awesomeAnalysis

This Form 4 filing reveals a substantial capital commitment by 10% owners Michael C. Skaff and V-Co Investors 3 LLC, totaling $7.17 million in Vivos Therapeutics securities. This significant investment, representing over 50% of the company's market capitalization, includes the conversion of a $1.4 million bridge promissory note into common stock and the acquisition of additional common stock, pre-funded warrants, and Series A and B common stock warrants. While a Schedule 13D filed on the same day disclosed a $2.39 million private placement, this Form 4 provides a much more comprehensive picture of the total capital infusion, indicating a strong vote of confidence and significantly bolstering the company's financial runway, which is critical for a nano-cap entity.